Journal
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
Volume 98, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.etap.2023.104074
Keywords
Comet assay; Wolfram; Pulmonary; Toxicity; Toxicology
Ask authors/readers for more resources
This study evaluated the pulmonary toxicity of tungsten by exposing male mice to tungsten particles and found increased genotoxicity at certain exposure levels. However, no adverse effects were observed on body weight, inflammation, or organ pathology. The study suggests that tungsten exhibits non-dose dependent genotoxicity without inflammation.
Tungsten is used in several applications and human exposure may occur. To assess its pulmonary toxicity, we exposed male mice to nose-only inhalation of tungsten particles at 9, 23 or 132 mg/m3 (Low, Mid and High exposure) (45 min/day, 5 days/week for 2 weeks). Increased genotoxicity (assessed by comet assay) was seen in bronchoalveolar (BAL) fluid cells at Low and High exposure. We measured acellular ROS production, and cannot exclude that ROS contributed to the observed genotoxicity. We saw no effects on body weight gain, pulmonary inflammation, lactate dehydrogenase or protein in BAL fluid, pathology of liver or kidney, or on sperm counts. In conclusion, tungsten showed non-dose dependent genotoxicity in the absence of inflammation and therefore interpreted to be primary genotoxicity. Based on genotoxicity, a Lowest Observed Adverse Effect Concentration (LOAEC) could be set at 9 mg/m3. It was not possible to establish a No Adverse Effect Concentration (NOAEC).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available